Guacetisal
Guacetisal|
|
| Systematic (IUPAC) name |
|---|
|
2-Methoxyphenyl 2-acetoxybenzoate |
| Clinical data |
|---|
| Trade names |
Broncaspin; Balsacetil; Guaiaspir; Prontomucil |
|---|
| Identifiers |
|---|
|
55482-89-8 |
|---|
|
N02BA14 |
|---|
| PubChem |
CID 68749 |
|---|
| ChemSpider |
61994 |
|---|
| Synonyms |
Aspirin guaiacol ester; O-Methoxyphenyl salicylate acetate |
|---|
| Chemical data |
|---|
| Formula |
C16H14O5 |
|---|
|
286.279 g/mol |
|---|
SMILES
- O=C(Oc1ccccc1C(=O)Oc2ccccc2OC)C
|
InChI=1S/C16H14O5/c1-11(17)20-13-8-4-3-7-12(13)16(18)21-15-10-6-5-9-14(15)19-2/h3-10H,1-2H3
Key:HSJFYRYGGKLQBT-UHFFFAOYSA-N
|
Guacetisal is a drug that has been used to treat inflammatory respiratory diseases.[1] Chemically, it is an ester resulting from the combination of aspirin and guaiacol.
References
- ↑ Vizioli, A; Zamperini, D; Ursaia, G (1982). "Clinical trial of guacetisal in aged subjects with inflammatory diseases of the respiratory tract". La Clinica terapeutica 103 (5): 527–33. PMID 6761043.
Non-steroidal anti-inflammatory drugs (NSAIDs) (primarily M01A and M02A, also N02BA) |
|---|
| Pyrazolones /
Pyrazolidines | |
|---|
| | Salicylates | |
|---|
| Acetic acid derivatives
and related substances | |
|---|
| | Oxicams | |
|---|
| Propionic acid derivatives
(profens) | |
|---|
| N-Arylanthranilic acids
(fenamates) | |
|---|
| | Coxibs | |
|---|
| | Other | |
|---|
| | | |
|---|
| | Description |
- Anatomy
- head
- neck
- arms
- chest and back
- diaphragm
- abdomen
- genital area
- legs
- Muscle tissue
- Physiology
|
|---|
| | Disease |
- Myopathy
- Soft tissue
- Connective tissue
- Congenital
- abdomen
- muscular dystrophy
- Neoplasms and cancer
- Injury
- Symptoms and signs
|
|---|
| | Treatment |
- Procedures
- Drugs
- anti-inflammatory
- muscle relaxants
|
|---|
|
|
